Intravenous (IV) infusions of the insulin-like growth factor-1 receptor (IGF-1R) veligrotug in people with thyroid eye disease were linked to significant improvement in patient-reported quality of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback